Business Wire

Affinity Brings Relationship Intelligence to Zoom With Affinity Meetings

Share

Affinity, the relationship intelligence platform for dealmakers, today released Affinity Meetings. By delivering relationship intelligence data from Affinity CRM directly within Zoom, Affinity Meetings provides dealmakers with intelligence about the people and companies they are meeting with to drive deals forward. This experience provides dealmakers with live access to the history of interactions with the people they are meeting, relationship intelligence data, and the ability to capture notes directly in their CRM. This enables more effective Zoom Meetings with founders, investors, and clients. Affinity Meetings is available to clients with Affinity Premium and Enterprise licenses.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220802005434/en/

“Dealmakers and their teams can be slowed or miss out on deals because of lack of meeting preparation and coordination,” says Andy Bryson, SVP of Product, Affinity. “Our goal is to provide the relationship insights our clients need to close their next deal. By providing on-demand access to relationship intelligence; the history of engagement with the firms they are meeting with; and the ability to view, create, and share notes, Affinity Meetings enables dealmakers to drive their deals forward faster.”

General partners, associates, and managing directors spend a huge amount of time in Zoom Meetings developing dealflow or moving deals forward. And this is increasing—over the last year, virtual meetings increased nearly 70%. Affinity research shows that almost 50% of dealmakers do their meeting prep in the moments before their Zoom Meetings start as they often do not have the time to get properly prepared for the meeting. This leads to time wasted determining what conversations occurred previously, misalignment with colleagues who are also involved in the deal, and ultimately, slowed dealflow or mistakes made that could kill a deal.

Affinity Meetings for Zoom closes that preparation gap by providing relationship intelligence directly in Zoom Meetings. This gives dealmakers a virtual refresher at the top of each call, live access to historical meeting agendas, and relationship context, including previous emails and meeting notes. As a result, dealmakers are empowered with the information they need to have a successful meeting, be aligned with their whole team on how the deal is progressing, and save time before and after the call.

“With Affinity Meetings we’re able to quickly reference a previous interaction or capture and save new details about a person or organization we’re meeting with,” said Chad Harding, Managing Partner, PEAK Technology Partners. “It minimizes the amount of windows we juggle during meetings and enables us to focus on our meeting attendees. It is particularly helpful when we are traveling and working off of a single screen."

Join the upcoming webinar “Keep Deals on Track with Affinity Meetings,” on August 30, 2022 as Affinity and Peak Technology Partners discuss how dealmakers can address common meeting challenges with intelligence about the companies and people you meet within Zoom.

About Affinity

Affinity is a relationship intelligence platform that empowers dealmakers in relationship-driven industries to find, manage and close more deals. With the most automated relationship intelligence insights and technology, Affinity enables leaders to drive deals, free themselves from data drudgery and ensure their teams can take action with confidence, knowing the context and history of every relationship. The Affinity platform, including Affinity CRM, is used by over 2,000 relationship-driven organizations worldwide. Founded in 2014, Affinity is headquartered in San Francisco and backed by leading investors, including Menlo Ventures, Advance Venture Partners, 8VC, and MassMutual Ventures.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caroline Kamerschen
caroline@bospar.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Caranx Medical announces successful world first robotic assisted transcatheter heart valve implantation in an animal16.4.2024 10:30:00 CEST | Press release

Caranx Medical (‘Caranx’), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the successful world first robotic assisted heart valve (aortic valve) implantation in an animal. The assisted heart valve implantation in the animal was successfully performed by Dr. Stéphane Lopez, Caranx CMO Dr. Eric Sejor, Caranx CTO Pierre Berthet-Rayne and Caranx team. “This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients' lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it” says Pierre Berthet-Rayne, PhD, co-founder and CTO of Caranx. “This major medical first lies not only in the technical achievement of Caranx Medical's engine

Arthur D. Little Publishes Human After All – Latest Edition of PRISM Magazine16.4.2024 10:00:00 CEST | Press release

Arthur D. Little (ADL) has published Human After All – the latest edition of its strategy and innovation magazine PRISM. As we enter the era of AI, the first edition of 2024 highlights the importance of taking a human-centric approach to business management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416226137/en/ Arthur D. Little has published Human After All – the latest edition of its strategy and innovation magazine PRISM. (Graphic: Business Wire) The magazine features seven key articles: Optimistic global CEOs focus on people and skills in an AI future - Our lead article shares highlights from the ADL 2024 CEO Insights Study, finding that CEOs are increasingly confident of future economic success. The people-centric lab of the future – how technology and AI can play a key role in driving breakthrough innovation by enabling people to become perfect innovators. The future workforce - Recruiting and retaining vital

Magnesium Capital closes oversubscribed inaugural Fund at €135m hard cap16.4.2024 09:32:00 CEST | Press release

Magnesium Capital, the Energy Transition buyout specialist, is delighted to announce the successful close of its inaugural Fund, Magnesium Capital I, at its hard cap of €135m, exceeding the €100m Fund target. The final close occurred less than a year after the Fund’s first close with Magnesium attracting blue-clip institutional investors from the US, Europe and the UK. Magnesium focuses on profitable European companies with proven technologies or tech-enabled services that are positively impacting the decarbonisation of the production, distribution and consumption of energy. The team has been backing the buyouts of such businesses for a number of years on a direct deal basis. Since inception, Magnesium has completed seven platform investments, signed six follow-on acquisitions and exited two investments for 4.2x gross MOIC. The combined impact of these portfolio companies already directly contributes to the avoidance of over 30 million tonnes of CO2 equivalent per annum. Ian Jones, Man

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH00216.4.2024 09:00:00 CEST | Press release

MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease indication Pouchitis. MRM Health’s MH002-PC-201 study was a multi-center, open-label clinical trial in 14 acute Pouchitis (PC) patients at multiple clinical sites in Belgium and Italy. The study was designed to evaluate safety (primary objective), initial efficacy, and mechanistic effects of MH002 over 8 weeks. More information about the trial is available at clinicaltrialsregister.eu. The trial met its primary objective with an excellent safety and tolerability at a fixed dose of 400mg per day over 8 weeks’ administration. Treatment-Emergent Adverse Events (TEAE) reported were predominantly mild and unrelated, and there was no evidence of adverse reactions related to MH002. It also demonstrated initial efficacy in clinically relevant parameters,

Bots Now Make Up Nearly Half of All Internet Traffic Globally16.4.2024 09:00:00 CEST | Press release

Thales, the cybersecurity leader that protects critical applications, APIs, and data, anywhere at scale, today announced the release of the 2024 Imperva Bad Bot Report, a global analysis of automated bot traffic across the internet. Nearly half (49.6%) of all internet traffic came from bots in 2023—a 2% increase over the previous year, and the highest level Imperva has reported since it began monitoring automated traffic in 2013. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240416225637/en/ ©Thales For the fifth consecutive year, the proportion of web traffic associated with bad bots grew to 32% in 2023, up from 30.2% in 2022, while traffic from human users decreased to 50.4%. Automated traffic is costing organizations billions (USD) annually due to attacks on websites, APIs, and applications. “Bots are one of the most pervasive and growing threats facing every industry,” says Nanhi Singh, General Manager, Application Secu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye